Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2874982 | The Annals of Thoracic Surgery | 2011 | 7 Pages |
Abstract
The use of ketorolac after coronary artery bypass grafting was associated with a lower rate of angiographically proven graft closure and suggests a mechanistic (improved graft patency) explanation for the previously reported survival benefit of ketorolac.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Milo MD, Jonathan MD, Thomas A. MD, Robert H. PhD,